ORLANDO (MedPage Today) -- Five myocardial infarctions in the Phase II ATOMIC-AHF study of the novel inotropic agent omecamtiv mecarbil might not be related to the drug, researchers suggested. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment